KISUNLA donanemab 350 mg/20 mL concentrated solution for intravenous infusion vial (2024-25)
Product name
KISUNLA donanemab 350 mg/20 mL concentrated solution for intravenous infusion vial
Sponsor name
Eli Lilly Australia Pty Ltd
Year Range
2024-25